Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.
Label date: 20260827 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
Mechanism: Topical corticosteroid with anti-inflammatory, antipruritic and vasoconstrictive actions; exact anti-inflammatory mechanism is unclear.
On both cards: Common side effects — Burning
Only on the Triamcinolone card: Used for — Corticosteroid-responsive dermatoses · Common side effects — Itching; Irritation; Dryness; Folliculitis · Warnings — Hypersensitivity to a component; Systemic absorption can suppress the HPA axis and cause Cushing-like effects or high blood glucose; Larger treated areas, prolonged treatment and occlusion increase systemic exposure; children are more susceptible
Mechanism: Corticosteroid acting on cell signaling, immune function and inflammation; precise mechanism in atopic dermatitis unknown.
On both cards: Warnings — Cataracts and glaucoma
Only on the Hydrocortisone Butyrate card: Used for — Mild-to-moderate atopic dermatitis from age 3 months, for the cited hydrocortisone butyrate lotion · Common side effects — Application site burning / pruritus; Application site erythema; Infantile acne; Skin depigmentation · Warnings — HPA axis suppression; Skin infections
Mechanism: Anti-inflammatory, antipruritic, vasoconstrictive; thought to induce lipocortins that inhibit phospholipase A2 and arachidonic acid release.
On both cards: Common side effects — Pruritus; Skin atrophy
Only on the Clobetasol Propionate card: Used for — Moderate to severe scalp psoriasis (adults) · Common side effects — Burning / stinging; Folliculitis; Telangiectasia · Warnings — HPA axis suppression; Cushing's syndrome, hyperglycemia; Local reactions; greater systemic risk in children; For the cited shampoo: limit treatment to 4 consecutive weeks and avoid the face, groin, armpits, eyes and lips
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.
Capsera